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Özet
Amaç
Fizyolojik koşullarda, normal hücreler enerjilerini sağlamak için 
başlıca glikolitik aerobik yolağı kullanırlar. Ancak, birçok kanser 
hücresi enerji üretimi için anaerobik glikolitik yolağı kullanır. Bu 
çalışmada, HL-60 akut promyelositik lösemi hücrelerinin enerji 
üretiminde karbonhidrat yolağının araştırılması amaçlanmıştır. 
Gereç ve Yöntemler
Lösemi hücreleri normal lökositler gibi aerobik ve anaerobik ko-
şullarda radyoaktif işaretlenmiş glukoz ile inkübe edildi ve gli-
kojen tüketimi, CO2 veya laktata parçalanan radyoaktif işaret-
li glukoz oranları, yani aerobik veya anaerobik glikoliz  oranla-
rı saptandı.  
Bulgular
Glikojen tüketimi aerobik lösemi hücre kültüründe normal löko-
sit hücre kültürlerindekine göre anlamlı derecede yüksek bulun-
du (P<0,01). Aerobik koşullardaki lösemi hücrelerinde anaerobik 
glikoliz oranı %93,8 di ve glikojenin kullanımı ile anaerobik ko-
şullarda  %7,31 oranında arttırılmış glikojenin kullanılmasıyla bu 
oran %96,6 ya çıkmıştır. 
Sonuç
HL-60 premyolositik lösemi hücrelerinde temel olarak anaerobik 
glikolizin enerji üretimi için daha etkin olduğu söylenebilir. Bu so-
nuç, premyolositik löseminin tedavisinde yeni tedavi yaklaşımla-
rın geliştirilmesi için daha kapsamlı çalışmalarla da desteklenir-
se önemli olabilir.
Anahtar Kelimeler
Enerji Metabolizması, HL-60 Premyolositik Lösemi Hücresi, Gli-
kojen Yıkımı.
Abstract
Aim
In physiological conditions, normal cells use mainly the glycolytic 
aerobic pathway to provide energy. However, most cancer cells 
utilize  anaerobic  glycolytic  way  for  energy  generation.  Aim 
of  this  study  was  to  investigate  the  carbohydrate  metabolic 
pathways  of  HL-60  acute  promyelocytic  leukemia  cells  for 
energy production.
Material and Methods
Leukemia cells as well as normal leukocytes were incubated with 
radiolabelled glucose in aerobic and anaerobic conditions and 
glycogen consumptions and the ratios of radiolabelled glucose 
catabolized into CO2 or lactate, that is, the rates of aerobic or 
anaerobic glycolysis, were determined. 
Results
The glycogen consumption was significantly higher in aerobic 
leukemia  cell  culture  than  normal  leukocyte  culture  (p<0.01). 
The rate of anaerobic glycolysis was 93.8% in leukemia cells in 
aerobic conditions and it increased to 96.6% while utilization of 
glycogen increased by 7.31% in anaerobic conditions. 
Conclusion
In  conclusion,  principally  anaerobic  glycolysis  is  effective  for 
energy generation in HL-60 promyelocytic leukemia cells. This 
result may be important for the development of new therapeutic 
approaches  in  the  treatment  of  promyelocytic  leukemia, 
requiring further comprehensive studies.
Keywords
Energy  Metabolism,  HL-60  Promyelocytic  Leukemia  Cell, 
Glycogen Degradation.
r A a
  l þ
a
t
n
ý
i
r
j
m
i
r
a
O
O
h
r
c
i
r
g
a
i
n
e
a
s
l
e
 
R
Journal of Clinical and Analytical Medicine 4 |
Mesane Tümörü ve Prostat Adenokarsinoma Birlikteliğinin Sağkalıma Etkisi  Impact of  Coexisting Bladder Tumour and Prostate Adenocarcinoma on Survival 
1.  Chan  JM,  Jou  RM  and  Carroll  PR.  The 
relative impact and future burden of 
prostate cancer in the United States. 
J Urol 2004;172:13-17
2.  Evans  HS,  Moller  H.  Recent  trends 
in  prostate  cancer  incidence  and 
mortality  in  southeast  England.  Eur 
Urol 2003;43:337-41
3.  Majeed  A,  Babb  P,  Jones  J,  Quinn  M. 
Trends  in  prostate  cancer  incidence, 
mortality  and  survival  in  England 
and  Whales  1971-1978.  BJU  Int 
2000;85:1058-62
4. Holund B. Latent prostatic cancer in a 
consecutive  autopsy  series.  Scand  J 
Urol Nephrol 1980;14:29-35
5. Scardino PT, Weaver R, Hudson MA. Early 
detection  of  prostate  cancer.  Hum 
Pathol 1992;23:211-22
6.  Stein JP, Skinner DG. Radical cystectomy 
for invasive bladder cancer: long-term 
results of a Standard procedure. World 
J Urol 2006;24:296-304
7. Abbas F, Biyabani SR, Pervez S. �ncidental 
prostate  cancer:  the  importance 
of  complete  prostatic  removal  at 
cystoprostatectomy  for  bladder 
cancer. Urol Int 2000;64:52-4
8.  Abbas  F,  Hochberg  D,  Civantos  F, 
Soloway  M.  Incidental  prostatic 
adenocarcinoma in patients undergoing 
radical cystoprostatectomy for bladder 
cancer. Eur Urol 1996;30:322-6
9.  Androulakakis  PA,  Schneider  HM, 
Jacobi  GH,  Hohenfellner  R.  Coincident 
vesical transitional cell carcinoma and 
prostatic  carcinoma:  clinical  features 
and treatment. Br J Urol 1987;53:153-6
10.  Babaian  RJ,  Troncoso  P,  Ayala  A. 
Transurethral-resection zone prostate 
cancer detected at cystoprostatectomy. 
A  detailed  histologic  analysis 
and  clinical  implications.  Cancer 
1991;67:1418-22
11.  Cindolo  L,  Benincasa  G,  Autorino  R, 
Domizio  S,  De  Rosa  G,  Testa  G,  et 
al.  Prevalence  of  silent  prostatic 
adenocarcinoma  in  165  patients 
undergone  cystoprostatectomy: 
a  retrospective  study.  Oncol  Rep 
2001;8:269-71
12. De Boccard GA, Chatelanat F, Graber P. 
Association de I’adenocarcinome de la 
prostate au carcinome transitionnel de 
la vessie. Helv Chir Acta 1985;20:533-4
13. Denton SE, Choy SH, Valk WL. Occult 
prostatic carcinoma diagnosed by the 
step�section technique of the surgical 
specimen. J Urol 1965;93:296-8
14.  Kabalin  JN,  McNeal  JE,  Price 
HM,  Freiha  FS,  Stamey  TA. 
�ncidental  adenocarcinoma  of  the 
prostate  in  patients  undergoing 
cystoprostatectomy for other causes: 
incidence, histology and morphometric 
observations. J Urol 1989;141:1091-4
15.  Autorino R, Di Lorenzo G, Damiano R, 
Giannarini G, De Sio M, Cheng L, et al. 
Pathology  of  the  prostate  in  radical 
cystectomy  specimens:  a  critical 
review Surg Oncol. 2009 ;18(1):73-84. 
16. Damiano R, Di Lorenzo G, Cantiello F, 
De  Sio  M,  Perdonà  S,  D’Armiento  M, 
et  al.  Clinicopathologic  features  of 
prostate  adenocarcinoma  incidentally 
discovered  at  the  time  of  radical 
cystectomy:  an  evidence  -  based 
analysis. Eur Urol 2007;52:648-657
17.  Pritchett  TR,  Moreno  J,  Warner  NE, 
Lieskovsky  G,  Nichols  PW,  Cook 
BA,  et  al.  Unsuspected  prostatic 
adenocarcinoma in patients who have 
undergone radical cystoprostatectomy 
for transitionnal cell carcinoma of the 
bladder. J Urol 1988;139:1214-6
18.  Delongchamps  NB,  Mao  K,  Theng  H, 
Zerbib  M,  Debre  B,  Peyromaure  M. 
Outcome  of  patients  with  fortuitous 
prostate  cancer  after  radical 
cystoprostatectomy for bladder cancer 
Eur Urol 2005;48:946-50
19. Esqueva R, Lorente JA, Mojal S, et al. 
Incidental prostatic adenocarcinoma in 
radical cystoprostatectomy specimens: 
the  impact  of  embedding  protocols 
(abstract).  Mod  Pathol  2008;21(suppl 
1):155A
20. Abdelhady M, Abusamra A, Pautler SE, 
Chin JL, Izawa JI. Clinically significant 
prostate  cancer  found  incidentally  in 
radical cystoprostatectomy specimens. 
BJU Int 2007;99:326-29
21. Aydın O, Cosar EF, Varinli S, Buğdaycı 
R, Tansuğ Z.  Prostatic intraepithelial 
neoplasia  in  prostate  specimens: 
frequency, significance and relationship 
to  the  sampling  of  the  specimen  (a 
retrospective study of 121 cases). Int 
Urol Nephrol 1999;31:687-697
22. Kouriefs C, Fazili T, Masood S, Naseem 
MS,  Mufti  GR.  Incidentally  detected 
prostate cancer in cystoprostatectomy 
specimens. Urol Int 2005;75:213-16
23. Prange W, Erbersdobler A, Hammerer 
P,  Graefen  M,  Hautmann  SH, 
Hautmann  RE,  et  al.  High-grade 
prostatic  intraepithelial  neoplasia  in 
cystoprostatectomy  specimens.  Eur 
Urol 2001;39(suppl 4):30-1
24.  Mazzucchelli  R,  Barbisan  F,  Scarpelli 
M, Lopez-Beltran A, van der Kwast TH, 
Cheng L, et al. Is incidentally detected 
prostate cancer in patients undergoing 
radical  cystoprostatectomy  clinically 
significant? 2009;131:279-283
25.  Moutzouris  G,  Barbatis  C,  Plastiras 
D,  Mertziotis  N,  Katsifotis  C, 
Presvelos  V,  et  al.  �ncidence  and 
histological  findings  of  unsuspected 
prostatic  adenocarcinoma  in  radical 
cystoprostatectomy  for  transitional 
cell carcinoma of the bladder. Scand J 
Urol Nephrol 1999,33:27-30
References
Sonuç
Radikal  sistoprostatektomi  spesmeninde  prostatın  PCa 
ile tutulması yaygın bir olaydır. Bizim çalışmamızda bu 
oran  %9.39  olarak  bulunmuştur.  �nsidental  PCa’ların 
çoğu bizim çalışmamızda da olduğu gibi organa sınırlı 
durumdadır.  Çalışmamızda  beraberinde  prostat  kanseri 
olan ya da olmayan invaziv mesane tümörlü hastaların 
mesane tümörü evre, grade ve hastalığa bağlı sağkalım 
oranları benzerdi. Saptanan insidental PCa klinik önemli 
olarak  değerlendirildiği  zaman  PSA  testi  postoperatif 
izlem  protokolüne  eklenmelidir.  Bize  göre  radikal 
sistoprostatektomiden  sonra  saptanan  insidental 
PCa  sağkalımı  etkilememektedir  ve  sağkalım  mesane 
tümörünün prognozuna bağlıdır. Journal of Clinical and Analytical Medicine 6 | Journal of Clinical and Analytical Medicine 2 |
other  chemicals  used  were  in  analytical  grade.  HL-
60  acute  promyelocytic  leukemia  cells  were  provided 
from  Memorial  Sloan-Kettering  Cancer  Center  NY,  NY 
and maintained at 37 °C in the medium of 5% CO2 and 
medium  of  RPMI  1640  supported  by  fetal  calf  serum 
10%, 2 μM L-Glutamine, 100 μg/mL streptomycine and 
100 U/ml penicilline. A total of seven cultures from HL-
60  acute  promyelocytic  leukemia  cells  were  prepared. 
For the preparation of normal leukocyte cultures blood 
sample was obtained from a healthy subject and put in 
tubes  with  acid-citrate-dextrose  (ACD).  Then  leukocyte 
isolation  was  performed  by  the  method  described 
previously by English and Anderson [15] and a total of 
seven cultures from normal leukocytes were prepared.
Radioactive  incubations  and  analysis  of  excreted  end 
products
Radioactive  incubations  were  performed  by  glucose  in 
which sixth carbon was labelled with radioactive Carbon 
14 (D-[6-C14] glucose). Amount of labelled glucose added 
to each culture was 25μCi D-[6-C14] glucose. Before the 
incubation procedure, both the normal leukocyte cultures 
and the HL-60 cell cultures were made up to adequate 
concentrations and each cell culture was separated into 
three groups. The first one was for the aerobic culture 
the second one was for the anaerobic culture after KCN 
addition defined by Tielens [9] and the last one was for 
the  determination  of  the  initial  glycogen  and  protein 
contents  of  the  cells.  Both  aerobic  and  anaerobic  cell 
cultures were immediately incubated with radiolabelled 
glucose  for  4  hours  in  a  specially  designed  chamber 
at  37  °C.  The  cultures  which  were  separated  for  the 
determination of zero time glycogen and protein levels 
were not incubated with radiolabelled glucose. Incubated 
cell cultures which catabolize externally given radioactive 
glucose  through  glycolysis  convert  it  into  products 
including lactate, acetate and propionic acid. Following 
incubation, the generated radioactive CO2 was collected 
in scintillation vials via nitrogen gas. Then, the content 
was  separated  as  supernatant  and  pellets.  By  using 
supernatant  layer,  end-products  of  glycolysis  (lactate, 
acetate and piruvate) were collected in scintillation vials 
by anion-exchange chromatography, and were calculated 
on standard graphics in Microsoft Excel program.
In  pellets,  protein  was  determined  by  modified  Lowry 
method  and  glycogen  by  Hassid  and  Abraham’s 
enzymatic method. Glucose in supernatant was measured 
enzymatically  by  glucose  oxidase  method.  Glycogen 
consumption  and  CO2  production  for  each  gram  of 
protein were calculated by using data obtained by the 
measurement of glycogen and protein found in the pellets.
Statistical Analyses
Statistical analysis of the data was done with 9.0 SPSS 
Package  programme  for  computer.  Kruskal-Wallis  and 
Mann  Wittney  U  tests  were  used  for  the  difference 
between groups. P<0.05 was assumed to be significant.  
Introduction
Some  structural  and  metabolic  alterations  can  occur 
with  malign  transformation  of  a  normal  living  cell  [1]. 
Metabolic changes may appear primarily in pathways of 
energy formation for the cell. Glucose and glutamine are 
the common sources of energy for both normal and malign 
cells [2]. 
Glycolysis  and  cell  respiration  function  in  both  ATP 
synthesis and metabolic pathways of carbohydrates and 
other compounds. Both normal and cancer cells use similar 
metabolic pathways for energy production but in varying 
rates [3]. In 1930, it was firstly reported by the Warburg 
that  anaerobic  glycolysis  rate  was  increased  in  cancer 
cells [4]. Some recent studies also indicated that cancer 
cells predominantly use anaerobic glycolysis rather than 
aerobic one for their energy generation but the rates differ 
[5-7]. For the increased protein synthesis and cell division, 
tumor cells function to provide energy by metabolizing the 
nutrients at an increased rate. To meet the requirements 
of increased metabolism, it may be beneficial for tumor 
cells to use the anaerobic glycolytic pathway, a quicker way 
to generate energy. But, on the other hand, they consume 
the organism’s supplies in a short period of time resulting 
in cashectia.  
The main way through which cells metabolize is mostly 
dependent  on  oxygen  level  in  the  medium.  In  the  case 
of high oxygen level, glucose is catabolized via aerobic 
glycolytic pathway followed by the insertion of degradation 
products  into  the  Krebs  cycle.  Then,  phosphate  with 
high energy is included into the electron transport chain 
resulting in energy gain [8,9]. When oxygen concentration 
is  inadequate,  the  anaerobic  glycolytic  pathway,  which 
is  less  efficient  than  aerobic  glycolysis,  is  completely 
activated, and cells maintain their viabilities even under 
low oxygen conditions [8]. Depending on the oxygen level, 
the selection of either the aerobic or anaerobic pathway 
in ATP synthesis is called “Pasteur Effect” [10-14]. The 
possession of this effect by tumor cells may provide them 
to maintain their viabilities, thus may influence the success 
of the treatment with anti-neoplastic agents which block 
energy metabolism of tumor cells. So, this study aimed to 
investigate the carbohydrate metabolic pathways of HL-60 
acute promyelocytic leukemia cells for energy production, 
thus  to  provide  appropriate  selection  and  development 
of antineoplastic agents targeting energy metabolism of 
these cells to increase the effectiveness of the treatment.   
Material and Methods
This  study  was  performed  within  the  collaboration  of 
Departments of “Biochemistry and Clinical Biochemistry” 
and  “Internal  Medicine”  of  Kırıkkale  University  School 
of  Medicine  and  Departments  of  “Hematology”  and 
“Biochemistry  and  Clinical  Biochemistry”  of  Gulhane 
School of Medicine.
Chemicals and biomaterials
D-[6-C14]  glucose  was  purchased  from  Amersham 
Company  and  hexokinase  and  glucose-6-phosphate 
dehydrogenase  enzymes  were  from  Boehringer.    All 
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Results
Table1  shows  the  amounts  of  glycogen  consumption, 
labelled and total end products of glycogen metabolism, 
CO2  and  lactate,  and  external  glucose  degradation  as 
percentage of internal glycogen degradation in normal 
and  leukemic  cell  lines  in  both  aerobic  and  anaerobic 
media.  Glycogen  consumption  was  significantly  higher 
in anaerobic leukocyte culture than aerobic one (p<0.01). 
Labelled and total amounts of end product lactate were 
higher (p<0.01 and p<0.01, respectively) and labelled and 
total amounts of end product CO2 were lower (p<0.01 and 
p<0.01, respectively) in anaerobic leukocyte culture when 
compared to aerobic one.
When aerobic HL-60 promyelocytic leukemia cell culture 
was  compared  with  aerobic  normal  leukocyte  culture, 
glycogen  consumption  was  found  to  be  significantly 
higher (p<0.01), labelled and total end product lactate 
was found to be higher (p<0.01) and labelled and total 
end product CO2 was found to be lower in leukemia cell 
culture  (p<0.01).  When  aerobic  HL-60  promyelocytic 
leukemia  cell  culture  was  compared  with  anaerobic 
normal  leukocyte  culture,  glycogen  consumption  was 
still significantly higher (p<0.01) but both labelled end 
products lactate and CO2 were lower (p<0.01 and p<0.01, 
respectively) while both total end products lactate and 
CO2  were  higher  (p<0.01  and  p<0.01,  respectively)  in 
leukemia cell culture.    
In anaerobic HL-60 promyelocytic leukemia cell culture 
glycogen consumption was significantly higher (p<0.05) 
and both labelled and total amounts of end product CO2 
were lower (p<0.01 and p<0.01, respectively) while both 
total and labelled amounts of end product lactate were 
higher (p<0.01 and p<0.01, respectively) than the ones 
in aerobic HL-60 promyelocytic leukemia cell culture. The 
findings were the same for the comparison of anaerobic 
HL-60 promyelocytic leukemia cell culture with aerobic 
and anaerobic normal leukocyte cultures.   
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Glycogen 
degradation
(pmol glu/h/μg prt)
mean±SD
Labelled end-products
(pmol glu/h/μg prt)
mean±SD
CO2                     Lactate
Total end-products
(pmol glu/h/μg prt)
mean±SD
CO2                 Lactate
External glucose 
degradation
(% of internal glycogen 
degradation)
Aerobic-Leucocyte 
culture (n=7)
927±17 78.7±4.3        3 .07±0.7                4979±276       94±570 8.83±1.13
Anaerobic-Leucocyte culture 
(n=7)
1562±68 9.3±2.0           83.6±2.5                334±14        3012±204 5.94±0.79
Aerobic-HL-60 acute 
promyelocytic leukemia 
cell culture (n=7)
2660±93 5.3±1.3           81.4±2.9                      342±22        5206±196 3.26±0.51
Anaerobic-HL-60 acute 
promyelocytic leukemia 
cell culture (n=7) 
2870±152 3.7±0.6         104.8±5.4                    200±14        5673±261 3.78±0.64
Table 1. Utilization of glycogen and production of CO2 and lactate by normal leukocytes and HL-60 
promyelocytic leukemia cells in aerobic and anaerobic cultures. 
Discussion
In the present study analysis of excreted end-products 
demonstrated that normal leukocytes use primarily the 
aerobic glycolysis in aerobic conditions but they shift their 
energy metabolism predominately to anaerobic glycolysis 
in anaerobic conditions. The results of this study also 
indicated that HL-60 promyelocytic leukemia cells use 
primarily  the  anaerobic  glycolytic  pathway  which  gets 
more predominant in anaerobic conditions. 
Warburg first reported in 1930 that cancer cells possess 
anaerobic glycolysis in high rate [4]. Later on numerous 
studies  were  performed  to  investigate  in  details  how 
carcinogenic  cells  use  the  metabolic  pathways  to 
generate ATP when compared to the function of original 
stem cells [16]. Indeed, the purpose of these studies was 
to develop more efficient chemotherapeutic agents. The 
findings indicated that cancer cells often use different 
metabolic ways as compared to those used by original 
cells. But, it was also found that a majority of cancer 
types  use  essentially  anaerobic  glycolysis  in  different 
rates,  and  their  cell  division  frequency  is  quite  high 
[17,18].  The  metabolic  rate  of  some  cancer  cells  may 
be  increased  up  to  approximately  400  times  [7].  This 
increase in metabolism also causes increases in enzyme 
activities of control points in glycolysis like hexokinase, 
phosphofructokinase  and  piruvate  kinase  [19].  Similar 
increases may also be seen in glucose carrier molecules 
[18]. Moreover, as addressed by Warburg [4], high rate 
of anaerobic glycolysis might not be associated with all 
types of cancer cells and a rather low cell division rate with 
a normal glycolysis could be seen in some cancer types 
like Morris hepatoma [20, 21]. The rates of metabolic 
pathways the cells use can be different although they 
function on some common ways in principal. 
Oxygen  level  and  nutrient  concentration  are  normally 
the main biological indicators which determine the exact 
metabolic pathway the cell can use to obtain ATP [8]. The 
main advantage of the use of anaerobic glycolysis with 
respect to tumor cell is to obtain ATP easier but it is an 
ineffective pathway. While 36-38 moles of ATP per mole 
of glucose are obtained through aerobic glycolysis only 2 
moles of ATP per mole of glucose are obtained through 
anaerobic glycolysis. Therefore 19 times more substrate 
is utilized in anaerobic glycolysis 
to obtain the same amount of 
ATP  obtained  through  aerobic 
glycolysis. 
The  conversion  of  the 
metabolism of normal or cancer 
cells from aerobic glycolysis into 
anaerobic glycolysis in reduced 
level  of  ambient  oxygen,  the 
so  called  Pasteur  Effect,  can 
accelerate  the  consumption  of 
glycogen  and  lipid  stores  [22, 
23]. Moreover, as a result of this 
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other  chemicals  used  were  in  analytical  grade.  HL-
60  acute  promyelocytic  leukemia  cells  were  provided 
from  Memorial  Sloan-Kettering  Cancer  Center  NY,  NY 
and maintained at 37 °C in the medium of 5% CO2 and 
medium  of  RPMI  1640  supported  by  fetal  calf  serum 
10%, 2 μM L-Glutamine, 100 μg/mL streptomycine and 
100 U/ml penicilline. A total of seven cultures from HL-
60  acute  promyelocytic  leukemia  cells  were  prepared. 
For the preparation of normal leukocyte cultures blood 
sample was obtained from a healthy subject and put in 
tubes  with  acid-citrate-dextrose  (ACD).  Then  leukocyte 
isolation  was  performed  by  the  method  described 
previously by English and Anderson [15] and a total of 
seven cultures from normal leukocytes were prepared.
Radioactive  incubations  and  analysis  of  excreted  end 
products
Radioactive  incubations  were  performed  by  glucose  in 
which sixth carbon was labelled with radioactive Carbon 
14 (D-[6-C14] glucose). Amount of labelled glucose added 
to each culture was 25μCi D-[6-C14] glucose. Before the 
incubation procedure, both the normal leukocyte cultures 
and the HL-60 cell cultures were made up to adequate 
concentrations and each cell culture was separated into 
three groups. The first one was for the aerobic culture 
the second one was for the anaerobic culture after KCN 
addition defined by Tielens [9] and the last one was for 
the  determination  of  the  initial  glycogen  and  protein 
contents  of  the  cells.  Both  aerobic  and  anaerobic  cell 
cultures were immediately incubated with radiolabelled 
glucose  for  4  hours  in  a  specially  designed  chamber 
at  37  °C.  The  cultures  which  were  separated  for  the 
determination of zero time glycogen and protein levels 
were not incubated with radiolabelled glucose. Incubated 
cell cultures which catabolize externally given radioactive 
glucose  through  glycolysis  convert  it  into  products 
including lactate, acetate and propionic acid. Following 
incubation, the generated radioactive CO2 was collected 
in scintillation vials via nitrogen gas. Then, the content 
was  separated  as  supernatant  and  pellets.  By  using 
supernatant  layer,  end-products  of  glycolysis  (lactate, 
acetate and piruvate) were collected in scintillation vials 
by anion-exchange chromatography, and were calculated 
on standard graphics in Microsoft Excel program.
In  pellets,  protein  was  determined  by  modified  Lowry 
method  and  glycogen  by  Hassid  and  Abraham’s 
enzymatic method. Glucose in supernatant was measured 
enzymatically  by  glucose  oxidase  method.  Glycogen 
consumption  and  CO2  production  for  each  gram  of 
protein were calculated by using data obtained by the 
measurement of glycogen and protein found in the pellets.
Statistical Analyses
Statistical analysis of the data was done with 9.0 SPSS 
Package  programme  for  computer.  Kruskal-Wallis  and 
Mann  Wittney  U  tests  were  used  for  the  difference 
between groups. P<0.05 was assumed to be significant.  
Introduction
Some  structural  and  metabolic  alterations  can  occur 
with  malign  transformation  of  a  normal  living  cell  [1]. 
Metabolic changes may appear primarily in pathways of 
energy formation for the cell. Glucose and glutamine are 
the common sources of energy for both normal and malign 
cells [2]. 
Glycolysis  and  cell  respiration  function  in  both  ATP 
synthesis and metabolic pathways of carbohydrates and 
other compounds. Both normal and cancer cells use similar 
metabolic pathways for energy production but in varying 
rates [3]. In 1930, it was firstly reported by the Warburg 
that  anaerobic  glycolysis  rate  was  increased  in  cancer 
cells [4]. Some recent studies also indicated that cancer 
cells predominantly use anaerobic glycolysis rather than 
aerobic one for their energy generation but the rates differ 
[5-7]. For the increased protein synthesis and cell division, 
tumor cells function to provide energy by metabolizing the 
nutrients at an increased rate. To meet the requirements 
of increased metabolism, it may be beneficial for tumor 
cells to use the anaerobic glycolytic pathway, a quicker way 
to generate energy. But, on the other hand, they consume 
the organism’s supplies in a short period of time resulting 
in cashectia.  
The main way through which cells metabolize is mostly 
dependent  on  oxygen  level  in  the  medium.  In  the  case 
of high oxygen level, glucose is catabolized via aerobic 
glycolytic pathway followed by the insertion of degradation 
products  into  the  Krebs  cycle.  Then,  phosphate  with 
high energy is included into the electron transport chain 
resulting in energy gain [8,9]. When oxygen concentration 
is  inadequate,  the  anaerobic  glycolytic  pathway,  which 
is  less  efficient  than  aerobic  glycolysis,  is  completely 
activated, and cells maintain their viabilities even under 
low oxygen conditions [8]. Depending on the oxygen level, 
the selection of either the aerobic or anaerobic pathway 
in ATP synthesis is called “Pasteur Effect” [10-14]. The 
possession of this effect by tumor cells may provide them 
to maintain their viabilities, thus may influence the success 
of the treatment with anti-neoplastic agents which block 
energy metabolism of tumor cells. So, this study aimed to 
investigate the carbohydrate metabolic pathways of HL-60 
acute promyelocytic leukemia cells for energy production, 
thus  to  provide  appropriate  selection  and  development 
of antineoplastic agents targeting energy metabolism of 
these cells to increase the effectiveness of the treatment.   
Material and Methods
This  study  was  performed  within  the  collaboration  of 
Departments of “Biochemistry and Clinical Biochemistry” 
and  “Internal  Medicine”  of  Kırıkkale  University  School 
of  Medicine  and  Departments  of  “Hematology”  and 
“Biochemistry  and  Clinical  Biochemistry”  of  Gulhane 
School of Medicine.
Chemicals and biomaterials
D-[6-C14]  glucose  was  purchased  from  Amersham 
Company  and  hexokinase  and  glucose-6-phosphate 
dehydrogenase  enzymes  were  from  Boehringer.    All 
HL-60 Akut Lösemi Hücrelerinde Anaerob Glikoliz / Anaerobic Glycolysis in HL-60 Acute Leukemia Cells Journal of Clinical and Analytical Medicine 8 | Journal of Clinical and Analytical Medicine 4 |
HL-60 Akut Lösemi Hücrelerinde Anaerob Glikoliz / Anaerobic Glycolysis in HL-60 Acute Leukemia Cells 
1. Fischer CP, Bode BP, Souba WW., Adaptive 
Alterations in Cellular Metabolism with   
Malignant Transformation.  Annals of 
Surgery, 1998, 227, 627-63.
2.  Sauer  L,  Stayman  J,  Dauchy  R.  Amino 
acid, glucose, and lactic acid utilization 
in vivo by rat tumors. Cancer Res, 1986 , 
46, 3469-3475.
3. Dienel GA, Hertz L. Glucose and lactate 
metabolism during brain activation. J 
Neurosci Res, 2001, 66, 824-838. 
4.  Warburg  O,  Metabolism  of  Tumors. 
London: Arnold Constable., 1930
5.  Rossignol  R,  Gilkerson  R,  Aggeler  R, 
Yamagata  K,  Remington  SJ,  Capaldi 
RA.  Energy  substrate  modulates 
mitochondrial structure and oxidative 
capacity  in  cancer  cells.  Cancer  Res, 
2004, 64, 985-993.
6.  Raghunand  N,  Gatenby  RA,  Gillies  RJ. 
Microenvironmental  and  cellular 
consequences of altered blood flow in 
tumours. Br J Radiol, 2003, 76, 11-22.
7.  Newsholme  EA,  Board  M,  Application 
of  metabolic-control  logic  to  fuel 
utilization and its significance in tumor 
cells, Adv Enzyme Regul, 1991,31, 225-
246. 
8.  Tielens  AGM.  Energy  generation  in 
parasitic  helminths.  Parasitology 
Today, 1994,10, 346-352.
9. Tielens AGM, Pas FAM, Heuvel JM, van 
den  Bergh  SG.  The  aerobic  energy 
metabolism  of  Schistosoma  mansoni 
miracidia. Molecular and Biochemical 
Parasitology, 1991,46, 181-184, .
10. Hardie DG., Metabolic control: a new 
solution to an old problem. Curr Biol, 
2000,19, 757-759.
11. Seagroves TN, Ryan HE, Lu H, Wouters 
BG, Knapp M, Thibault P, Laderoute K, 
Johnson RS. Transcription factor HIF-1 
is a necessary mediator of the pasteur 
effect  in  mammalian  cells.  Mol  Cell 
Biol, 2001,21, 3436-3444, .
12. Herting B, Meixensberger J, Roggendorf 
W, Reichmann H., Metabolic patterns in 
meningiomas, J Neurooncol, 2003,65, 
119-123.
13.  Summers  JE,  Ratcliffe  RG,  Jackson 
MB.  Anoxia  tolerance  in  the  aquatic 
monocot  Potamogeton  pectinatus 
absence  of  oxygen  stimulates 
elongation  in  association  with  an 
unusually  large  pasteur  effect.  J  Exp 
Bot, 2000,51, 1413-1422, . 
14.  Boyunaga  H,  Schmitz  MGJ,  Brouwers 
JFHM,  Van  Hellemond  JJ,  Tielens 
AG.  Fasciola,  Hepatica  miracidia 
are  dependent  on  respiration  and 
endogenous glycogen degradation for 
their energy generation. Parasitology, 
2001,122, 169-173. 
15.  English  D,  Anderson  BR.,  Single 
step  separation  of  red  blood  cells, 
granulcytes  and  mononuclear 
leukocytes  on  discontinuous  density 
gradients  of  Ficoll-Hypaque.  J. 
Immunol. Methods, 1974,5, 249-259.
16. Chesney J, Mitchell R, Benigni F, Bacher 
M, Spiegel L, Al-Abed Y, Han JH, Metz 
C, Bucala R., An inducible gene product 
for  6-phosphofructo-2-kinase  with 
an AU-rich instability element: role in 
tumor cell glycolysis and the Warburg 
effect. Proc Natl Acad Sci USA, 1999, 
96, 3047-3052.
17.  Dang  CV,  Lewis  BC,  Dolde  C,  Dang 
G,  Shim  H.,  Oncogenes  in  tumor 
metabolism,  tumorigenesis,  and 
apoptosis. J Bioenerg Biomembr, 1997, 
29, 345-354.
18. Eigenbrodt E, Reinacher M, Scheefers-
Borchel U, Scheefers H, Friis R., Double 
role for pyruvate kinase type M2 in the 
expansion of phosphometabolite pools 
found in tumor cells. Crit Rev Oncog, 
1992,3, 91-115.
19. Kress S, Stein A, Maurer P, Weber B, 
Reichert  J,  Buchmann  A,  Huppert  P, 
Schwarz  M.  Expression  of  hypoxia-
inducible genes in tumor cells. J Cancer 
Res Clin Oncol, 1998,124, 315-320. 
20.  Parry  DM,  Pedersen  PL.  Intracellular 
localization  and  properties  of 
particulate hexokinase in the Novikoff 
ascites  tumor.  Evidence  for  an  outer 
mitochondrial  membrane  location.  J 
Biol Chem, 1983,258, 10904-10912.
21.  Morris  HP.  Chemically  induced 
hepatoma cell line. Recent Results in 
Cancer Research, 1954,44, 103-114, .
22.  Hochachka  PW.,  Mechanism  and 
evolution  of  hypoxia-tolerance  in 
humans.  Journal  of  Experimental 
Biology, 1998,201, 1243-1254.
23.  Scatena  R,  Bottoni  P,  Martorana  GE, 
Ferrari F, De Sole P, Rossi C, Giardina 
B.  Mitochondrial  respiratory  chain 
dysfunction, a non-receptor-mediated 
effect  of  synthetic  PPAR-ligands: 
biochemical  and  pharmacological 
implications.  Biochem  Biophys  Res 
Commun, 2004,319, 967-973. 
24. Iwata K, Ogata S, Okumura K, Taguchi 
H.  Induction  of  differentiation  in 
human promyelocytic leukemia HL-60 
cell line by niacin-related compounds. 
Biosci  Biotechnol  Biochem,  2003,67, 
1132-1135, . 
25.  Morshed  SR,  Tokunaga  T,  Otsuki  S, 
Takayama  F,  Satoh  T,  Hashimoto 
K,  Yasui  T,  Okamura  M,  Shimada  J, 
Kashimata  M,  Sakagami  H.  Effect 
of  antitumor  agents  on  cytotoxicity 
induction  by  sodium  fluoride. 
Anticancer Res, 2003,23, 4729-4736.
26.  Scatena  R,  Bottoni  P,  Vincenzoni  F, 
Messana  I,  Martorana  GE,  Nocca  G, 
De  Sole  P,  Maggiano  N,  Castagnola 
M,  Giardina  B.  Bezafibrate  induces 
a  mitochondrial  derangement  in 
human cell lines: a PPAR-independent 
mechanism  for  a  peroxisome 
proliferator. Chem Res Toxicol, 2003, 
16, 1440-1447.
References
alteration, the effect of chemotherapy used to regulate 
the energy metabolism of cancer cells remains limited 
[24-26]. 
In our study, as it was reflected by the level of radiolabelled 
end product CO2 aerobic glycolysis was the predominant 
way of metabolism (96%) in aerobic leukocyte culture. 
But in anaerobic media leukocytes shifted their energy 
to mainly anaerobic glycolysis (90%) with an increase in 
consumption of glycogen by 73.8%, showing prominent 
Pasteur  Effect.  The  ratios  of  radiolabelled  glucose 
catabolized into CO2  or lactate, that is, the rates it was 
directed to either anaerobic or aerobic way were also 
investigated  on  aerobic  HL-60  leukemia  cell  line  and 
significant  differences  were  found  when  compared  to 
anaerobic and aerobic control leukocyte cultures. The rate 
of aerobic glycolysis was only 6.2% in aerobic conditions 
that is the main way of glycolysis was anaerobic (93.8%) 
in  HL-60  promyelocytic  leukemia  cells.    The  level  of 
anaerobic glycolysis increased to 96.6%, and utilization 
of glycogen increased by 7.31%, when oxygen use of HL-
60 promyelocytic leukemia cells was inhibited by KCN.
These results indicate that HL-60 acute promyelocytic 
leukemia cells metabolize glucose prominently through 
the  anaerobic  glycolysis  and  endogenous  glycogen 
degradation is the main pathway for energy generation. 
These results also indicate that the Pasteur Effect is also 
validated in HL-60 promyelocytic leukemia cells.
In  conclusion,  it  is  evident  that  principally  anaerobic 
glycolysis  is  effective  for  energy  generation  in  HL-60 
promyelocytic  leukemia  cells  in  aerobic  conditions.  On 
the  other  hand,  the  rate  of  anaerobic  glycolysis  gets 
more prominent in anaerobic conditions. This result may 
be  important  for  the  development  of  new  therapeutic 
approaches  in  the  treatment  of  acute  promyelocytic 
leukemia, requiring further comprehensive studies.